Delphi Programming For Dummies 317.pdf ((FULL)) ✅

by eanrsmo | 0 Comments | 20 Nov 2022

Delphi Programming For Dummies 317.pdf ((FULL)) ✅

Download ► DOWNLOAD

Delphi Programming For Dummies 317.pdf

the modified delphi process led to the development of three treatment protocols to support dosing and administration of medical cannabis in patients with chronic pain. the clinician may consider moving patients across the streams as a means to tailor the approach. patient participation in the treatment decisions may enhance adherence and the likelihood of improved patient outcomes. the clinical success of medical cannabis should not be limited to pain scores and should consider improvements in function and quality of life.

the routine protocol is recommended for most patients (fig. 2 ). the delphi process led to agreement that a patient may initiate with 5 mg twice daily (bid) of a cbd-predominant strain and up-titrate by 10 mg/day (5 mg cbd bid) every 23 days up to 40 mg cbd per day. a key reason for choosing to initiate with a cbd-predominant variety was to prioritize safety as cbd is highly tolerable, does not induce euphoria, and has a low risk for adverse effects (taylor et al. 2018 ; larsen and shahinas 2020 ). in addition, many cbd-predominant preparations contain a small percentage of thc (bonn-miller et al. 2017 ; lachenmeier et al. 2020 ).

the specific protocol is recommended for patients with low back or lower extremity pain and for patients with other co-morbidities or when a first-time patient. the delphi process led to agreement that a patient may initiate with 5 mg twice daily (bid) of a cbd-predominant strain and up-titrate by 10 mg/day (5 mg cbd bid) every 23 days up to 40 mg cbd per day. this protocol is tailored to the patient’s age, level of pain and functionality to avoid premature titration to a high dose of cbd that may increase the risk of adverse effects and limit patient compliance. the cbd-predominant preparation should be chosen to reduce the risk of euphoria and nausea (taylor et al. 2018 ; larsen and shahinas 2020 ).
the modified delphi process led to the development of three treatment protocols to support dosing and administration of medical cannabis in patients with chronic pain. the clinician may consider moving patients across the streams as a means to tailor the approach. patient participation in the treatment decisions may enhance adherence and the likelihood of improved patient outcomes. the clinical success of medical cannabis should not be limited to pain scores and should consider improvements in function and quality of life.
the routine protocol is recommended for most patients (fig. 2 ). the delphi process led to agreement that a patient may initiate with 5 mg twice daily (bid) of a cbd-predominant strain and up-titrate by 10 mg/day (5 mg cbd bid) every 23 days up to 40 mg cbd per day. a key reason for choosing to initiate with a cbd-predominant variety was to prioritize safety as cbd is highly tolerable, does not induce euphoria, and has a low risk for adverse effects (taylor et al. 2018 ; larsen and shahinas 2020 ). in addition, many cbd-predominant preparations contain a small percentage of thc (bonn-miller et al. 2017 ; lachenmeier et al. 2020 ).
5ec8ef588b

Delphi Programming For Dummies 317.pdf ((FULL)) ✅

Delphi Programming For Dummies 317.pdf ((FULL)) ✅

Latest Posts

Recent Comments